litlas
ログインアカウント作成

Robert G. Maki

1990–2025 年に発表

175
論文数
48,384
被引用数
108
h 指数
169
i10 指数

被引用数

Robert G. Maki の年別被引用数1986 年: 被引用 1 件1991 年: 被引用 4 件1992 年: 被引用 4 件1993 年: 被引用 5 件1994 年: 被引用 12 件1995 年: 被引用 6 件1996 年: 被引用 8 件1997 年: 被引用 4 件1998 年: 被引用 9 件1999 年: 被引用 10 件2000 年: 被引用 9 件2001 年: 被引用 8 件2002 年: 被引用 13 件2003 年: 被引用 23 件2004 年: 被引用 52 件2005 年: 被引用 95 件2006 年: 被引用 107 件2007 年: 被引用 155 件2008 年: 被引用 202 件2009 年: 被引用 259 件2010 年: 被引用 309 件2011 年: 被引用 437 件2012 年: 被引用 513 件2013 年: 被引用 451 件2014 年: 被引用 430 件2015 年: 被引用 404 件2016 年: 被引用 379 件2017 年: 被引用 412 件2018 年: 被引用 388 件2019 年: 被引用 1,163 件2020 年: 被引用 1,380 件2021 年: 被引用 1,484 件2022 年: 被引用 1,322 件2023 年: 被引用 939 件2024 年: 被引用 1,376 件2025 年: 被引用 577 件2026 年: 被引用 8 件1987〜1990 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 4,088 件、この内訳の 27.8%中国: 引用元論文 1,764 件、この内訳の 12%イタリア: 引用元論文 832 件、この内訳の 5.7%イギリス: 引用元論文 794 件、この内訳の 5.4%ドイツ: 引用元論文 775 件、この内訳の 5.3%フランス: 引用元論文 734 件、この内訳の 5%日本: 引用元論文 583 件、この内訳の 4%オランダ: 引用元論文 470 件、この内訳の 3.2%スペイン: 引用元論文 456 件、この内訳の 3.1%カナダ: 引用元論文 432 件、この内訳の 2.9%オーストラリア: 引用元論文 318 件、この内訳の 2.2%韓国: 引用元論文 308 件、この内訳の 2.1%
0%27.8%その他 21.3%

機関

分野

  • Medicine70.3%
  • Biochemistry, Genetics and Molecular Biology21%
  • Immunology and Microbiology4.5%
  • Engineering1.6%
  • Computer Science0.5%
  • Mathematics0.5%
  • その他1.6%

トピック

  • Sarcoma Diagnosis and Treatment7.9%
  • Lung Cancer Treatments and Mutations3.9%
  • Cancer Cells and Metastasis3.4%
  • Gastrointestinal Tumor Research and Treatment3.4%
  • Cancer Genomics and Diagnostics2.9%
  • Cancer Immunotherapy and Biomarkers2.8%
  • その他75.7%

共著者

全論文

検索で開く
  1. A framework for advancing our understanding of cancer-associated fibroblasts

    著者: Erik Sahai, Igor Astsaturov, Edna Cukierman, David G. DeNardo, Mikala Egeblad, Ronald M. Evans, Douglas T. Fearon, Florian R. Greten, Sunil R. Hingorani, Tony Hunter, Richard O. Hynes, Rakesh K. Jain, Tobias Janowitz, Claus Jørgensen, Alec C. Kimmelman, Mikhail G. Kolonin, Robert G. Maki, Scott Powers, Ellen Puré, Daniel C. Ramirez, Ruth Scherz‐Shouval, Mara H. Sherman, Sheila A. Stewart, Thea D. Tlsty, David A. Tuveson, Fiona M. Watt, Valerie M. Weaver, Ashani T. Weeraratna, Zena Werb - Nature reviews. Cancer 2020 被引用: 3,780

  2. Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial

    著者: Hussein A. Tawbi, Melissa Burgess, Vanessa Bolejack, Brian A. Van Tine, Scott M. Schuetze, James Hu, Sandra P. D’Angelo, Steven Attia, Richard F. Riedel, Dennis A. Priebat, Sujana Movva, Lara E. Davis, Scott H. Okuno, Damon R. Reed, John Crowley, Lisa H. Butterfield, Ruth Salazar, Jaime Rodriguez‐Canales, Alexander J. Lazar, Ignacio I. Wistuba, Laurence H. Baker, Robert G. Maki, Denise K. Reinke, Shreyaskumar Patel - The Lancet Oncology 2017 被引用: 1,423

  3. Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer

    著者: Eunice L. Kwak, Yung‐Jue Bang, D. Ross Camidge, Alice T. Shaw, Benjamin Solomon, Robert G. Maki, Sai‐Hong Ignatius Ou, Bruce J. Dezube, Pasi A. Jänne, Daniel B. Costa, Marileila Varella‐Garcia, Woo Ho Kim, Thomas J. Lynch, Panos Fidias, Hannah Stubbs, Jeffrey A. Engelman, Lecia V. Sequist, Weiwei Tan, Leena Gandhi, Mari Mino–Kenudson, Greg C. G. Wei, S. Martin Shreeve, Mark J. Ratain, Jeffrey Settleman, James G. Christensen, Daniel A. Haber, Keith D. Wilner, Ravi Salgia, Geoffrey I. Shapiro, Jeffrey W. Clark, A. John Iafrate - New England Journal of Medicine 2010 被引用: 4,504

  4. Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial

    著者: George D. Demetri, Peter Reichardt, Yoon‐Koo Kang, Jean‐Yves Blay, Piotr Rutkowski, Hans Gelderblom, Peter Hohenberger, Michael Leahy, Margaret von Mehren, Heikki Joensuu, Giuseppe Badalamenti, Martin E. Blackstein, Axel Le Cesne, Patrick Schöffski, Robert G. Maki, Sebastian Bauer, Binh Bui Nguyen, Jianming Xu, Toshirou Nishida, John Chung, Christian Kappeler, Iris Kuss, Dirk Laurent, Paolo G. Casali - The Lancet 2012 被引用: 1,401

  5. Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial

    著者: George D. Demetri, Margaret von Mehren, Robin L. Jones, Martee L. Hensley, Scott M. Schuetze, Arthur P. Staddon, Mohammed Milhem, A. Elias, Kristen N. Ganjoo, Hussein A. Tawbi, Brian Andrew Van Tine, Alexander I. Spira, Andrew Dean, Nushmia Z. Khokhar, Youn Choi Park, Roland E. Knoblauch, Trilok Parekh, Robert G. Maki, Shreyaskumar Patel - Journal of Clinical Oncology 2015 被引用: 834

  6. Sorafenib for Advanced and Refractory Desmoid Tumors

    著者: Mrinal M. Gounder, Michelle R. Mahoney, Brian A. Van Tine, Vinod Ravi, Steven Attia, Hari A. Deshpande, Abha A. Gupta, Mohammed Milhem, Robert M. Conry, Sujana Movva, Michael J. Pishvaian, Richard F. Riedel, Tarek Sabagh, William D. Tap, Natally Horvat, Ethan Basch, Lawrence H. Schwartz, Robert G. Maki, Narasimhan P. Agaram, Robert A. Lefkowitz, Yousef Mazaheri, Rikiya Yamashita, John J. Wright, Amylou C. Dueck, Gary K. Schwartz - New England Journal of Medicine 2018 被引用: 449

  7. Clinical genomic profiling in the management of patients with soft tissue and bone sarcoma

    著者: Mrinal M. Gounder, Narasimhan P. Agaram, Sally E. Trabucco, Victoria Robinson, Richard Ferraro, Sherri Z. Millis, Anita Krishnan, Jessica Lee, Steven Attia, Wassim Abida, Alexander Drilon, Ping Chi, Sandra P. D’ Angelo, Mark A. Dickson, Mary Lou Keohan, Ciara M. Kelly, Mark Agulnik, Sant P. Chawla, Edwin Choy, Rashmi Chugh, Christian F. Meyer, Parvathi A. Myer, Jessica L. Moore, Ross A. Okimoto, Raphael E. Pollock, Vinod Ravi, Arun S. Singh, Neeta Somaiah, Andrew J. Wagner, John H. Healey, Garrett M. Frampton, Jeffrey M. Venstrom, Jeffrey S. Ross, Marc Ladanyi, Samuel Singer, Murray F. Brennan, Gary K. Schwartz, Alexander J. Lazar, David M. Thomas, Robert G. Maki, William D. Tap, Siraj M. Ali, Dexter X. Jin - Nature Communications 2022 被引用: 193

  8. Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial

    著者: Patrick Schöffski, Sant P. Chawla, Robert G. Maki, Antoîne Italiano, Hans Gelderblom, Edwin Choy, Giovanni Grignani, Veridiana Pires de Camargo, Sebastian Bauer, Sun Young Rha, Jean‐Yves Blay, Peter Hohenberger, David R. D’Adamo, Matthew Guo, Bartosz Chmielowski, Axel Le Cesne, George D. Demetri, Shreyaskumar Patel - The Lancet 2016 被引用: 766

  9. Patient-derived xenografts effectively capture responses to oncology therapy in a heterogeneous cohort of patients with solid tumors

    著者: Eugene Izumchenko, K. Paz, Daniel Ciznadija, Ido Sloma, Amanda Katz, David Vasquez-Dunddel, Ido Ben-Zvi, Justin Stebbing, William P. McGuire, William Proctor Harris, Robert G. Maki, Andrew Gaya, A Bedi, Stergios Zacharoulis, Rajani Ravi, Leonard H. Wexler, Mohammad Obaidul Hoque, Carlos Rodríguez‐Galindo, Harvey I. Pass, Nir Peled, Angela M. Davies, Ronnie Morris, Manuel Hidalgo, D. Sidransky - Annals of Oncology 2017 被引用: 337

  10. Tumor-associated macrophages and macrophage-related immune checkpoint expression in sarcomas

    著者: Amanda R. Dancsok, Dongxia Gao, Anna F. Lee, Sonja E. Steigen, Jean‐Yves Blay, David M. Thomas, Robert G. Maki, Torsten O. Nielsen, Elizabeth G. Demicco - OncoImmunology 2020 被引用: 178

  11. Randomized Double-Blind Phase II Study of Regorafenib in Patients With Metastatic Osteosarcoma

    著者: Lara E. Davis, Vanessa Bolejack, Christopher W. Ryan, Kristen N. Ganjoo, Elizabeth T. Loggers, Sant P. Chawla, Mark Agulnik, Michael B. Livingston, Damon R. Reed, Vicky L. Keedy, Daniel A. Rushing, Scott H. Okuno, Denise K. Reinke, Richard F. Riedel, Steven Attia, Leo Mascarenhas, Robert G. Maki - Journal of Clinical Oncology 2019 被引用: 262

  12. A novel WWTR1‐CAMTA1 gene fusion is a consistent abnormality in epithelioid hemangioendothelioma of different anatomic sites

    著者: Costantino Errani, Lei Zhang, Yun Shao Sung, Mihai Hajdu, Samuel Singer, Robert G. Maki, John H. Healey, Cristina R. Antonescu - Genes Chromosomes and Cancer 2011 被引用: 546

  13. Clinical Cancer Advances 2020: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology

    著者: Merry Jennifer Markham, KERRI WACHTER, Neeraj Agarwal, Monica M. Bertagnolli, Susan M. Chang, William Dale, Catherine Diefenbach, Carlos Rodríguez‐Galindo, Daniel J. George, Timothy D. Gilligan, R. Donald Harvey, Melissa L. Johnson, Randall J. Kimple, Miriam A. Knoll, Noelle K. LoConte, Robert G. Maki, Jane Meisel, Jeffrey A. Meyerhardt, Nathan A. Pennell, Gabrielle B. Rocque, Michael S. Sabel, Richard L. Schilsky, Bryan J. Schneider, William D. Tap, Robert G. Uzzo, Shannon N. Westin - Journal of Clinical Oncology 2020 被引用: 169

  14. The management of desmoid tumours: A joint global consensus-based guideline approach for adult and paediatric patients

    著者: Ben Alman, Steven Attia, Christina Baumgarten, Charlotte Benson, Jean‐Yves Blay, Sylvie Bonvalot, Jessica Breuing, Ken Cardona, Paolo G. Casali, Frits van Coevorden, Chiara Colombo, Angelo Paolo Dei Tos, Palma Dileo, Andrea Ferrari, Marco Fiore, Anna Maria Frezza, J. Santiago García, Rebecca A. Gladdy, Mrinal M. Gounder, Alessandro Gronchi, Rick L. Haas, Sam Hackett, Florian Haller, Peter Hohenberger, Olga Husson, Robin L. Jones, Ian Judson, Bernd Kasper, Akira Kawai, Vlada Kogosov, Alex J. Lazar, Robert G. Maki, Tim Mathes, Christina Messiou, Fariba Navid, Yoshihiro Nishida, Elena Palassini, Nicolas Penel, Robert Pollock, Dawid Pieper, Marlene Portnoy, Chandrajit P. Raut, Evelyne Roets, Sergio Sandrucci, Marta Sbaraglia, Silvia Stacchiotti, Katherine A. Thornton, Winette van der Graaf, Kim van der Zande, Winan J. van Houdt, Víctor M. Villalobos, Andrew J. Wagner, Eva Wardelmann, Markus Wartenberg, Sarah Watson, Aaron R. Weiss, Nikolaos Zafiropoulos - European Journal of Cancer 2020 被引用: 478

  15. Phase II Randomized Study of CMB305 and Atezolizumab Compared With Atezolizumab Alone in Soft-Tissue Sarcomas Expressing NY-ESO-1

    著者: Sant P. Chawla, Brian A. Van Tine, Seth M. Pollack, Kristen N. Ganjoo, Anthony D. Elias, Richard F. Riedel, Steven Attia, Edwin Choy, Scott H. Okuno, Mark Agulnik, Margaret von Mehren, Michael B. Livingston, Vicki L. Keedy, Claire F. Verschraegen, Tony Philip, G. Chet Bohac, Sergey Yurasov, Adam Yakovich, Hailing Lu, Michael Chen, Robert G. Maki - Journal of Clinical Oncology 2021 被引用: 50

  16. Randomized Phase II Study of Gemcitabine and Docetaxel Compared With Gemcitabine Alone in Patients With Metastatic Soft Tissue Sarcomas: Results of Sarcoma Alliance for Research Through Collaboration Study 002

    著者: Robert G. Maki, J. Kyle Wathen, Shreyaskumar Patel, Dennis A. Priebat, Scott H. Okuno, Brian L. Samuels, Michael Fanucchi, David C. Harmon, Scott M. Schuetze, Denise K. Reinke, Peter F. Thall, Robert S. Benjamin, Laurence H. Baker, Martee L. Hensley - Journal of Clinical Oncology 2007 被引用: 733

  17. Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy

    著者: Jordi Barretina, Barry S. Taylor, Shantanu Banerji, Alexis Ramos, Mariana Lagos‐Quintana, Penelope DeCarolis, Kinjal Shah, Nicholas D. Socci, Barbara A. Weir, Alan L. Ho, Derek Y. Chiang, Boris Reva, Craig H. Mermel, Gad Getz, Yevgenyi Antipin, Rameen Beroukhim, John E. Major, Charles Hatton, Richard Nicoletti, Megan Hanna, Ted Sharpe, Tim Fennell, Kristian Cibulskis, Robert C. Onofrio, Tsuyoshi Saito, Neerav Shukla, Christopher Lau, Sven Nelander, Serena J. Silver, Carrie Sougnez, Agnès Viale, Wendy Winckler, Robert G. Maki, Levi A. Garraway, Alex Lash, Heidi Greulich, David E. Root, William R. Sellers, Gary K. Schwartz, Cristina R. Antonescu, Eric S. Lander, Harold Varmus, Marc Ladanyi, Chris Sander, Matthew Meyerson, Samuel Singer - Nature Genetics 2010 被引用: 726

  18. Crizotinib inALK-Rearranged Inflammatory Myofibroblastic Tumor

    著者: James E. Butrynski, David R. D’Adamo, Jason L. Hornick, Paola Dal Cin, Cristina R. Antonescu, Suresh C. Jhanwar, Marc Ladanyi, Marzia Capelletti, Scott J. Rodig, Nikhil H. Ramaiya, Eunice L. Kwak, Jeffrey W. Clark, Keith D. Wilner, James G. Christensen, Pasi A. Jänne, Robert G. Maki, George D. Demetri, Geoffrey I. Shapiro - New England Journal of Medicine 2010 被引用: 867

  19. Risk assessment in solitary fibrous tumors: validation and refinement of a risk stratification model

    著者: Elizabeth G. Demicco, Michael J. Wagner, Robert G. Maki, Vishal Gupta, Ilya Iofin, Alexander J. Lazar, Wei‐Lien Wang - Modern Pathology 2017 被引用: 441

  20. Advances in sarcoma genomics and new therapeutic targets

    著者: Barry S. Taylor, Jordi Barretina, Robert G. Maki, Cristina R. Antonescu, Samuel Singer, Marc Ladanyi - Nature reviews. Cancer 2011 被引用: 433

  21. Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma Network

    著者: George D. Demetri, Cristina R. Antonescu, Bodil Bjerkehagen, Judith V.M.G. Bovée, Kjetil Boye, Matías Chacón, Angelo Paolo Dei Tos, Jayesh Desai, Jonathan A. Fletcher, Hans Gelderblom, Suzanne George, Alessandro Gronchi, Rick L. Haas, Nadia Hindi, Peter Hohenberger, Heikki Joensuu, Robin L. Jones, Ian Judson, Y-K Kang, Akira Kawai, Alexander J. Lazar, Axel Le Cesne, Roberta Maestro, Robert G. Maki, Javier Martín‐Broto, Shreyaskumar Patel, Frédérique Penault‐Llorca, Chandrajit P. Raut, Piotr Rutkowski, Akmal Safwat, Marta Sbaraglia, Inga‐Marie Schaefer, Lin Shen, César Serrano, P. Schöffski, Silvia Stacchiotti, Kirsten Sundby Hall, William D. Tap, David M. Thomas, Jonathan C. Trent, Claudia Valverde, Winette T.A. van der Graaf, M. von Mehren, Andrew J. Wagner, E. Wardelmann, Yoichi Naito, John Zalcberg, Jean‐Yves Blay - Annals of Oncology 2020 被引用: 145

  22. NCCN Task Force Report: Update on the Management of Patients with Gastrointestinal Stromal Tumors

    著者: George D. Demetri, Margaret von Mehren, Cristina R. Antonescu, Ronald P. DeMatteo, Kristen N. Ganjoo, Robert G. Maki, Peter W. T. Pisters, Chandrajit P. Raut, Richard F. Riedel, Scott M. Schuetze, Hema Sundar, Jonathan C. Trent, Jeffrey D. Wayne - Journal of the National Comprehensive Cancer Network 2010 被引用: 1,222

  23. Primary and Secondary Kinase Genotypes Correlate With the Biological and Clinical Activity of Sunitinib in Imatinib-Resistant Gastrointestinal Stromal Tumor

    著者: Michael C. Heinrich, Robert G. Maki, Christopher L. Corless, Cristina R. Antonescu, Amy Harlow, Diana Griffith, Ajia Town, Arin McKinley, Wen‐Bin Ou, Jonathan A. Fletcher, Christopher D.�M. Fletcher, Xin Huang, Darrel P. Cohen, Charles M. Baum, George D. Demetri - Journal of Clinical Oncology 2008 被引用: 806

  24. Phase II Study of Sorafenib in Patients With Metastatic or Recurrent Sarcomas

    著者: Robert G. Maki, David R. D’Adamo, Mary Louise Keohan, Michael Saulle, Scott M. Schuetze, Samir D. Undevia, Michael B. Livingston, Matthew M. Cooney, Martee L. Hensley, Monica Mita, Chris H. Takimoto, Andrew S. Kraft, Anthony Elias, Bruce Brockstein, Nathalie E. Blachère, Mark Edgar, Lawrence H. Schwartz, Li-Xuan Qin, Cristina R. Antonescu, Gary K. Schwartz - Journal of Clinical Oncology 2009 被引用: 573